Prog Holdings, Inc. (Nasdaq: PRG) is a biopharmaceutical company dedicated to developing and commercializing novel solutions for the diagnosis and treatment of disease. The company's primary focus is on its patented oral drug delivery technologies. Historically known as Progenity, Inc., the company rebranded to reflect its evolution and focus on its pipeline of therapeutics and innovative delivery systems. Its operating subsidiary, Biora Therapeutics, advances this mission.

Founded in

United States